Peringatan Keamanan

Acute oral toxicity (LD50): 3950 mg/kg Guinea pig

Cyclandelate

DB04838

small molecule approved

Deskripsi

A direct-acting smooth muscle relaxant used to dilate blood vessels. It may cause gastrointestinal distress and tachycardia. Cyclandelate is not approved for use in the U.S. or Canada, but is approved in various European countries.

Struktur Molekul 2D

Berat 276.3707
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Well absorbed following oral administration.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Makanan

1 Data
  • 1. Take with food. Food reduces irritation.

Interaksi Obat

758 Data
Ceritinib Cyclandelate may increase the bradycardic activities of Ceritinib.
Ivabradine Cyclandelate may increase the bradycardic activities of Ivabradine.
Ruxolitinib Ruxolitinib may increase the bradycardic activities of Cyclandelate.
Cimetidine The serum concentration of Cyclandelate can be increased when it is combined with Cimetidine.
Clopidogrel The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Cyclandelate.
Efavirenz The serum concentration of Cyclandelate can be decreased when it is combined with Efavirenz.
Melatonin The therapeutic efficacy of Cyclandelate can be decreased when used in combination with Melatonin.
Nafcillin The therapeutic efficacy of Cyclandelate can be decreased when used in combination with Nafcillin.
Nitroprusside Cyclandelate may increase the hypotensive activities of Nitroprusside.
Dantrolene The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Cyclandelate.
Lithium citrate The risk or severity of adverse effects can be increased when Cyclandelate is combined with Lithium citrate.
Lithium carbonate The risk or severity of adverse effects can be increased when Cyclandelate is combined with Lithium carbonate.
Lithium hydroxide The risk or severity of adverse effects can be increased when Cyclandelate is combined with Lithium hydroxide.
Boceprevir The serum concentration of Cyclandelate can be increased when it is combined with Boceprevir.
Ibutilide Ibutilide may increase the arrhythmogenic activities of Cyclandelate.
Hyoscyamine Hyoscyamine may increase the arrhythmogenic activities of Cyclandelate.
Atropine Atropine may increase the arrhythmogenic activities of Cyclandelate.
Adenosine Adenosine may increase the arrhythmogenic activities of Cyclandelate.
Moricizine Moricizine may increase the arrhythmogenic activities of Cyclandelate.
Levosimendan Levosimendan may increase the arrhythmogenic activities of Cyclandelate.
Procainamide Procainamide may increase the arrhythmogenic activities of Cyclandelate.
Tocainide Tocainide may increase the arrhythmogenic activities of Cyclandelate.
Flecainide Flecainide may increase the arrhythmogenic activities of Cyclandelate.
Encainide Encainide may increase the arrhythmogenic activities of Cyclandelate.
Ajmaline Ajmaline may increase the arrhythmogenic activities of Cyclandelate.
Aprindine Aprindine may increase the arrhythmogenic activities of Cyclandelate.
Carteolol Cyclandelate may increase the arrhythmogenic activities of Carteolol.
Metipranolol Cyclandelate may increase the arrhythmogenic activities of Metipranolol.
Azimilide Cyclandelate may increase the arrhythmogenic activities of Azimilide.
Tedisamil Cyclandelate may increase the arrhythmogenic activities of Tedisamil.
Vernakalant Cyclandelate may increase the arrhythmogenic activities of Vernakalant.
Cariporide Cyclandelate may increase the arrhythmogenic activities of Cariporide.
Xylometazoline Cyclandelate may increase the arrhythmogenic activities of Xylometazoline.
Sparteine Cyclandelate may increase the arrhythmogenic activities of Sparteine.
Fasudil Cyclandelate may increase the arrhythmogenic activities of Fasudil.
Melperone Cyclandelate may increase the arrhythmogenic activities of Melperone.
Tropisetron Cyclandelate may increase the arrhythmogenic activities of Tropisetron.
Simendan Cyclandelate may increase the arrhythmogenic activities of Simendan.
Spiradoline Cyclandelate may increase the arrhythmogenic activities of Spiradoline.
Pilsicainide Cyclandelate may increase the arrhythmogenic activities of Pilsicainide.
Cicletanine Cyclandelate may increase the arrhythmogenic activities of Cicletanine.
Cibenzoline Cyclandelate may increase the arrhythmogenic activities of Cibenzoline.
Nizofenone Cyclandelate may increase the arrhythmogenic activities of Nizofenone.
Prajmaline Cyclandelate may increase the arrhythmogenic activities of Prajmaline.
Tiracizine Cyclandelate may increase the arrhythmogenic activities of Tiracizine.
Ethacizine Cyclandelate may increase the arrhythmogenic activities of Ethacizine.
Lorajmine Cyclandelate may increase the arrhythmogenic activities of Lorajmine.
Bunaftine Cyclandelate may increase the arrhythmogenic activities of Bunaftine.
Lorcainide Cyclandelate may increase the arrhythmogenic activities of Lorcainide.
Hydroquinine Cyclandelate may increase the arrhythmogenic activities of Hydroquinine.
Bioallethrin Cyclandelate may increase the arrhythmogenic activities of Bioallethrin.
Fosfructose Cyclandelate may increase the arrhythmogenic activities of Fosfructose.
Hydroquinidine Cyclandelate may increase the arrhythmogenic activities of Hydroquinidine.
SOR-C13 Cyclandelate may increase the arrhythmogenic activities of SOR-C13.
Digoxin Digoxin may increase the arrhythmogenic activities of Cyclandelate.
Acetyldigitoxin Acetyldigitoxin may increase the arrhythmogenic activities of Cyclandelate.
Deslanoside Deslanoside may increase the arrhythmogenic activities of Cyclandelate.
Cymarin Cyclandelate may increase the arrhythmogenic activities of Cymarin.
Metildigoxin Cyclandelate may increase the arrhythmogenic activities of Metildigoxin.
Acetyldigoxin Cyclandelate may increase the arrhythmogenic activities of Acetyldigoxin.
Niguldipine Cyclandelate may increase the arrhythmogenic activities of Niguldipine.
Bretylium Bretylium may increase the arrhythmogenic activities of Cyclandelate.
Isradipine Isradipine may increase the arrhythmogenic activities of Cyclandelate.
Diltiazem Diltiazem may increase the arrhythmogenic activities of Cyclandelate.
Trimethadione Trimethadione may increase the arrhythmogenic activities of Cyclandelate.
Amlodipine Amlodipine may increase the arrhythmogenic activities of Cyclandelate.
Nimodipine Nimodipine may increase the arrhythmogenic activities of Cyclandelate.
Lercanidipine Lercanidipine may increase the arrhythmogenic activities of Cyclandelate.
Lamotrigine Lamotrigine may increase the arrhythmogenic activities of Cyclandelate.
Cinnarizine Cinnarizine may increase the arrhythmogenic activities of Cyclandelate.
Nicardipine Nicardipine may increase the arrhythmogenic activities of Cyclandelate.
Verapamil Verapamil may increase the arrhythmogenic activities of Cyclandelate.
Losartan Losartan may increase the arrhythmogenic activities of Cyclandelate.
Levomenthol Levomenthol may increase the arrhythmogenic activities of Cyclandelate.
Zonisamide Zonisamide may increase the arrhythmogenic activities of Cyclandelate.
Nitrendipine Nitrendipine may increase the arrhythmogenic activities of Cyclandelate.
Perhexiline Perhexiline may increase the arrhythmogenic activities of Cyclandelate.
Bepridil Bepridil may increase the arrhythmogenic activities of Cyclandelate.
Nimesulide Nimesulide may increase the arrhythmogenic activities of Cyclandelate.
Prenylamine Prenylamine may increase the arrhythmogenic activities of Cyclandelate.
Flunarizine Cyclandelate may increase the arrhythmogenic activities of Flunarizine.
Fluspirilene Cyclandelate may increase the arrhythmogenic activities of Fluspirilene.
Clevidipine Cyclandelate may increase the arrhythmogenic activities of Clevidipine.
Methsuximide Cyclandelate may increase the arrhythmogenic activities of Methsuximide.
Seletracetam Cyclandelate may increase the arrhythmogenic activities of Seletracetam.
Nylidrin Cyclandelate may increase the arrhythmogenic activities of Nylidrin.
Ziconotide Cyclandelate may increase the arrhythmogenic activities of Ziconotide.
Dotarizine Cyclandelate may increase the arrhythmogenic activities of Dotarizine.
Nilvadipine Cyclandelate may increase the arrhythmogenic activities of Nilvadipine.
Tranilast Cyclandelate may increase the arrhythmogenic activities of Tranilast.
Agmatine Cyclandelate may increase the arrhythmogenic activities of Agmatine.
Fendiline Cyclandelate may increase the arrhythmogenic activities of Fendiline.
Eperisone Cyclandelate may increase the arrhythmogenic activities of Eperisone.
Trimebutine Cyclandelate may increase the arrhythmogenic activities of Trimebutine.
Pinaverium Cyclandelate may increase the arrhythmogenic activities of Pinaverium.
Nicorandil Cyclandelate may increase the arrhythmogenic activities of Nicorandil.
Barnidipine Cyclandelate may increase the arrhythmogenic activities of Barnidipine.
Aranidipine Cyclandelate may increase the arrhythmogenic activities of Aranidipine.
Azelnidipine Cyclandelate may increase the arrhythmogenic activities of Azelnidipine.
Benidipine Cyclandelate may increase the arrhythmogenic activities of Benidipine.

Target Protein

Voltage-dependent calcium channel subunit alpha-2/delta-1 CACNA2D1
Liver carboxylesterase 1 CES1

Referensi & Sumber

Synthesis reference: Nauta, W.T.; U.S. Patent 2,707,193; April 26,1955; assigned to N.V. Koninklijke Pharmaceutische Fabrieken Voorbeen Brocades Stheeman & Pharmacia, Netherlands. Flitter, D.; U.S. Patent 3,663,597; May 16, 1972; assigned to American Home Products Corporation.

Contoh Produk & Brand

Produk: 1 • International brands: 3
Produk
  • Cyclospasmol Tablets 200mg
    Tablet • 200 mg / tab • Oral • Canada • Approved
International Brands
  • Capilan — Takeda
  • Cyclergine
  • Cyclospasmol — lves

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul